tiprankstipranks
Trending News
More News >
Guorui Properties Ltd (HK:2329)
:2329

Guorui Properties Ltd (2329) AI Stock Analysis

Compare
0 Followers

Top Page

HK:2329

Guorui Properties Ltd

(2329)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 4o)
Rating:41Neutral
Price Target:
HK$0.12
▼(-13.57% Downside)
The overall stock score of 41 reflects significant financial challenges, including declining revenues, high leverage, and cash flow issues. Technical analysis provides a neutral outlook, while valuation metrics are weak due to negative earnings and no dividend yield. These factors collectively indicate a high-risk investment with limited upside potential.
Positive Factors
Diverse Revenue Streams
Guorui Properties' diverse revenue streams, including sales, leasing, and property management, provide resilience against market fluctuations.
Strategic Partnerships
Partnerships with local governments and developers can lead to joint ventures, expanding project opportunities and revenue potential.
Sustainable Development Practices
Commitment to sustainable practices can enhance brand reputation and attract environmentally conscious clients, supporting long-term growth.
Negative Factors
High Leverage
High leverage increases financial risk, potentially limiting the company's ability to invest in new projects and manage economic downturns.
Declining Revenue
Declining revenue and profitability indicate operational challenges, which may hinder the company's ability to sustain growth and market position.
Cash Flow Challenges
Cash flow instability can impact liquidity, affecting the company's ability to meet obligations and invest in growth opportunities.

Guorui Properties Ltd (2329) vs. iShares MSCI Hong Kong ETF (EWH)

Guorui Properties Ltd Business Overview & Revenue Model

Company DescriptionGlory Health Industry Limited, an investment holding company, engages in the development of real estate properties in the People's Republic of China. The company operates through four segments: Property Development, Primary Land Construction and Development Services, Property Investment, and Property Management and Related Services. The Property Development segment develops and sells commercial and residential properties. The Primary Land Construction and Development Services segment provides primary land development services, including services for resettlement, and construction of land infrastructure and ancillary public facilities on land owned by the local governments. The Property Investment segment engages in the rental of investment properties. The Property Management and Related Services segment offers property management and related services. It primarily serves individual purchasers for residential properties, as well as various types of corporations and other business entities for commercial properties. The company was formerly known as Guorui Properties Limited and changed its name to Glory Health Industry Limited in July 2022. Glory Health Industry Limited was founded in 1994 and is headquartered in Beijing, China. Glory Health Industry Limited is a subsidiary of Alltogether Land Company Limited.
How the Company Makes MoneyGuorui Properties Ltd generates revenue primarily through the sale of residential and commercial properties, which constitutes its core revenue stream. The company also earns income from leasing and rental services of its developed properties, providing a steady cash flow. Additionally, Guorui Properties engages in property management services, further diversifying its income sources. Strategic partnerships with local governments and other real estate developers enhance its project pipeline and can lead to joint ventures, which may contribute significantly to its earnings. The company also benefits from favorable market conditions, governmental policies supporting real estate development, and its reputation for delivering high-quality projects.

Guorui Properties Ltd Financial Statement Overview

Summary
Guorui Properties Ltd faces significant financial difficulties, with declining revenues, ongoing losses, high leverage, and cash flow challenges. The income statement, balance sheet, and cash flow scores are all low, indicating poor financial health and stability.
Income Statement
The income statement reveals a declining trend in revenue with negative profitability. The gross profit margin has been inconsistent, and the company has been experiencing net losses in recent years. Revenue growth has been negative, and EBIT and EBITDA margins have decreased significantly, highlighting operational challenges.
Balance Sheet
The balance sheet shows a relatively high debt-to-equity ratio, indicating significant leverage, which may pose financial risks. Stockholders’ equity has been decreasing, affecting the equity ratio negatively. The return on equity has been negative due to ongoing net losses, pointing to challenges in generating returns for shareholders.
Cash Flow
Cash flow analysis indicates instability, with a significant decline in free cash flow and operating cash flow over recent periods. The lack of positive free cash flow growth and a negative operating cash flow to net income ratio highlight cash flow management issues, potentially impacting liquidity.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.04B2.71B2.51B3.90B9.90B5.77B
Gross Profit127.66M555.56M-50.28M113.52M1.25B980.32M
EBITDA-59.80M295.14M-145.86M-325.93M581.55M1.09B
Net Income-1.41B-1.24B-563.97M-912.78M228.33M98.74M
Balance Sheet
Total Assets56.83B57.20B56.35B57.39B61.07B67.52B
Cash, Cash Equivalents and Short-Term Investments171.08M158.10M152.22M189.51M556.87M1.65B
Total Debt22.59B22.79B22.18B21.25B20.95B23.52B
Total Liabilities44.63B44.83B42.57B43.01B45.64B52.41B
Stockholders Equity9.70B9.93B11.17B11.73B12.71B12.49B
Cash Flow
Free Cash Flow632.07M678.26M452.11M413.47M4.07B4.67B
Operating Cash Flow630.31M679.53M512.92M606.31M4.35B4.94B
Investing Cash Flow105.81M146.72M58.95M-305.41M184.15M-2.78B
Financing Cash Flow-770.21M-830.50M-627.40M-630.90M-5.65B-1.11B

Guorui Properties Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.14
Price Trends
50DMA
0.12
Positive
100DMA
0.15
Negative
200DMA
0.12
Positive
Market Momentum
MACD
<0.01
Negative
RSI
57.25
Neutral
STOCH
53.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2329, the sentiment is Positive. The current price of 0.14 is above the 20-day moving average (MA) of 0.13, above the 50-day MA of 0.12, and above the 200-day MA of 0.12, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 57.25 is Neutral, neither overbought nor oversold. The STOCH value of 53.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2329.

Guorui Properties Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
48
Neutral
HK$221.84M-5.21-5.13%-76.39%-1142.86%
44
Neutral
HK$311.26M-0.18-34.31%-63.41%77.97%
41
Neutral
HK$617.77M-0.41-13.99%-0.38%-296.42%
41
Neutral
HK$129.20M-0.04-35.96%-5.63%-36.30%
40
Underperform
HK$126.66M-0.01-70.13%-16.86%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2329
Guorui Properties Ltd
0.14
0.04
46.32%
HK:6158
Zhenro Properties Group Limited
0.03
-0.03
-48.21%
HK:0865
Jiande International Holdings Ltd.
0.04
0.02
123.53%
HK:2772
Zhongliang Holdings Group Company Limited
0.07
-0.03
-30.69%
HK:3639
Yida China Holdings Ltd.
0.05
-0.05
-48.45%

Guorui Properties Ltd Corporate Events

Glory Health Industry Issues Update on Debt Restructuring and Asset Sales After Auditor Disclaimer
Jan 6, 2026

Glory Health Industry Limited has provided a quarterly update on efforts to address the disclaimer of opinion issued by its auditors on the 2024 consolidated financial statements, which stemmed from doubts over the group’s ability to realize assets and meet liabilities in the normal course of business. Since its last update, the group has secured an extension approval from Bank of Tianjin on a RMB1.314 billion loan, but broader debt restructuring talks with financial institutions and other creditors remain ongoing. Several key asset disposal and project transfer initiatives, including the overall transfers of its Shenyang company and Foshan Shengpingli project, the sale of Beijing North Fifth Building, and the disposal of Hainan Yunlong Property, are still in the stage of seeking buyers and negotiating terms, with management indicating that successful completion would ease liquidity pressures and significantly reduce total debt. The group is also continuing applications to relevant government authorities for the return of land tied to its Shenyang and Chongming Island projects, and has pledged to make further announcements as material progress is achieved, underscoring the critical importance of these measures for its financial stability and creditor confidence.

The most recent analyst rating on (HK:2329) stock is a Hold with a HK$0.12 price target. To see the full list of analyst forecasts on Guorui Properties Ltd stock, see the HK:2329 Stock Forecast page.

Glory Health Industry Secures Waiver for Board Compliance Amid Sector Challenges
Dec 11, 2025

Glory Health Industry Limited, a company incorporated in the Cayman Islands, has announced a significant update regarding its board composition and compliance with stock exchange listing rules. Following the resignation of Mr. Yuan Hao as an independent non-executive director, the company faced challenges in appointing a suitable replacement due to concerns about the property sector’s operating conditions in China and misalignment with candidates’ appointment terms. Consequently, the company applied for and was granted a waiver from strict compliance with certain listing rules, allowing more time to appoint Mr. Wang Shiyu as an independent non-executive director. This waiver, subject to change by the stock exchange, highlights the company’s proactive measures to maintain compliance and stabilize its board amid challenging market conditions.

The most recent analyst rating on (HK:2329) stock is a Hold with a HK$0.12 price target. To see the full list of analyst forecasts on Guorui Properties Ltd stock, see the HK:2329 Stock Forecast page.

Glory Health Industry Appoints New Independent Director
Dec 1, 2025

Glory Health Industry Limited has appointed Mr. Wang Shiyu as an independent non-executive director, chairman of the internal control committee, and a member of the audit committee, effective December 1, 2025. Mr. Wang brings extensive experience in investment banking, mergers and acquisitions, and corporate globalization, which is expected to strengthen the company’s governance and strategic direction.

The most recent analyst rating on (HK:2329) stock is a Hold with a HK$0.11 price target. To see the full list of analyst forecasts on Guorui Properties Ltd stock, see the HK:2329 Stock Forecast page.

Glory Health Industry Limited Announces Board Composition and Committees
Dec 1, 2025

Glory Health Industry Limited has announced the composition of its board of directors and the establishment of four committees to oversee various aspects of its operations. The board comprises both executive and independent non-executive directors, with Zhang Zhangsun serving as the chairman. This announcement highlights the company’s commitment to structured governance and operational oversight, which may enhance its industry positioning and stakeholder confidence.

The most recent analyst rating on (HK:2329) stock is a Hold with a HK$0.11 price target. To see the full list of analyst forecasts on Guorui Properties Ltd stock, see the HK:2329 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 03, 2025